Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy.
Matsukuma K, Nishio S, Tasaki S, Park J, Nasu H, Yoshimitsu T, Tasaki K, Katsuda T, Terada A, Tsuda N, Sanada S, Ushijima K. Matsukuma K, et al. Among authors: katsuda t. Kurume Med J. 2024 Mar 29. doi: 10.2739/kurumemedj.MS7012004. Online ahead of print. Kurume Med J. 2024. PMID: 38556270 Free article.
Comparison of secondary cytoreductive surgery plus chemotherapy with chemotherapy alone for recurrent epithelial ovarian, tubal, or peritoneal carcinoma: A propensity score-matched analysis of 112 consecutive patients.
Takahashi A, Kato K, Matsuura M, Katsuda T, Matoda M, Nomura H, Okamoto S, Kanao H, Kondo E, Omatsu K, Utsugi K, Takeshima N. Takahashi A, et al. Among authors: katsuda t. Medicine (Baltimore). 2017 Sep;96(37):e8006. doi: 10.1097/MD.0000000000008006. Medicine (Baltimore). 2017. PMID: 28906381 Free PMC article.
Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer.
Izuchi D, Fukagawa S, Yotsumoto F, Shigekawa K, Yoshikawa K, Hirakawa T, Kiyoshima C, Ouk NS, Urushiyama D, Katsuda T, Miyata K, Ito T, Kurakazu M, Araki R, Sanui A, Miyahara D, Murata M, Ito H, Shirota K, Kuroki M, Yasunaga S, Miyamoto S. Izuchi D, et al. Among authors: katsuda t. Anticancer Res. 2018 Jul;38(7):4347-4351. doi: 10.21873/anticanres.12735. Anticancer Res. 2018. PMID: 29970572
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.
Miyata K, Yotsumoto F, Fukagawa S, Kiyoshima C, Ouk NS, Urushiyama D, Ito T, Katsuda T, Kurakazu M, Araki R, Sanui A, Miyahara D, Murata M, Shirota K, Yagi H, Takono T, Kato K, Yaegashi N, Akazawa K, Kuroki M, Yasunaga S, Miyamoto S. Miyata K, et al. Among authors: katsuda t. Anticancer Res. 2017 Jul;37(7):3955-3960. doi: 10.21873/anticanres.11779. Anticancer Res. 2017. PMID: 28668900
150 results